Dr. B J Srinivasa

Dr. Srinivasa B. J. specializes in administering medical oncology treatments for a wide range of cancers. His academic credentials include MBBS, MD (General Medicine), and DNB (Medical Oncology) degrees from the country’s prestigious medical institutes. He earned a gold medal in DNB for his exemplary performance. His primary interest lies in the systemic management of breast cancer, GI cancer, lymphoma, and myeloma.

With a keen interest in clinical research and tumor genetics, he strives to help his patients with personalized treatment strategies that focus on addressing the specific health needs of each patient. He has gathered a wealth of experience from his previous associations with reputable medical organizations, such as the Manipal Tumkur Hospital (Tumkur), Father Muller Medical College (Mangalore), and Vaatsalya Hospital (Shivamogga).

●       Indian subset analysis of a phase IIIb open-label study of afatinib in epidermal growth factor receptor tyrosine kinase inhibitor-naïve patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer. Oncol J India 2021; 5:116-8.

●       Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies. Front Oncol. 2021 Jul 9;11:709877. 

●       Sepsis Mimicking TTP-Case Report and Review of Literature. Journal of Surgery & Anesthesia Research. December 2020:1-2.

●       The fundamentals to minimize the culture failure in hematological malignancies. OALib. 2020;07(09):1-6.

●       Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study. Advances in Breast Cancer Research. 2020;09(04):110-118.

●       Reversible hypopigmentation with pazopanib. Indian J Med Paediatr Oncol 2018;39:519-20.

●       Breast Metastasis from Adenocarcinoma of Lung: A Case Report. SEAJCRR. (2016); 5(5): 2453-2458.

●       Combined DPD and UGT1A1 mutation in a single patient: a case report. Journal of Pharmacogenomics & Pharmacoproteomics. 2017;08(01).

●       Adenocarcinoma  Colon Masquerading as Acute Leukemia. Journal of Case Reports, 2012; 2(2): 67-71.

●       Case of fosphenytoin-induced acute cerebellar dysfunction and pituitary bleeding causing central diabetes insipidus in a case of AML M2 during allogenic hematopoietic stem cell transplant. Int J Pharmacol and Clin Sci 2012;1:111-4.

●       Primary Rhadbdomyosarcoma of breast. Journal of Case Reports, 2013; 3(1): 130-133.

●       Efficacy study of metronomic chemotherapy in metastatic NSCLC and correlation with VEGF and Thrombospondin levels WCRJ 2017; 4 (2): e878.

●       KDR gene as a Predictive Biomarker of Response to Regorafenib in Patients with Metastatic Colorectal Cancer (mCRC). Journal of Pharmacogenomics & Pharmacoproteomics. 2017;08(03).

●       Prospective Analysis of Patients Treated with Chemotherapy in Metastatic Adenocarcinoma of Lung—Single Centre Experience. Journal of Cancer Therapy. 2017;08(09):838-844.

●       Efficacy Study of Metronomic Chemotherapy in Metastatic Triple Negative Breast Cancer and Correlation with VEGF, TSP Levels. Advances in Breast Cancer Research. 2018;07(02):107-119.

●       Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience. Clin Med Insights Oncol. 2018 Jun 28;12:1179554918782475.